Status:
COMPLETED
Abdominal Aortic Calcium and CAD-RADS 2.0
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Coronary Artery Disease (CAD)
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: Abdominal aortic calcium (AAC) is a marker of systemic atherosclerosis and may predict cardiovascular outcomes similarly to coronary artery calcium (CAC). This study evaluates the predicti...
Detailed Description
Introduction Coronary artery calcium (CAC) scoring, developed and validated using computed tomography (CT), is a well-established technique for quantifying coronary atherosclerosis and assessing cardi...
Eligibility Criteria
Inclusion
- patients with chest pain or discomfort who were scheduled to undergo cardiac CT for CAC and CCTA
- determined by the treating physician for the evaluation of CAD
Exclusion
- severe allergies to contrast agents
- metallic implants in the lumbar spine
- renal function abnormalities (estimated glomerular filtration rate \[eGFR\] \< 60)
- abdominal aortic aneurysms
- prior coronary artery stent placements or bypass surgery
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06956924
Start Date
June 1 2021
End Date
May 31 2023
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Kaohsiung City, Niao Sung, Taiwan, 833